查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750805

医药运输服务市场规模、份额、趋势分析报告：按类型、服务、供应链、地区、细分市场预测，2025-2030 年

Pharmaceutical Transportation Services Market Size, Share & Trends Analysis Report By Type (Biopharmaceuticals, Pharmaceuticals), By Service (Air Freight, Sea Freight, Overland), By Supply Chain, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

医药运输服务市场成长与趋势：

根据Grand View Research, Inc.的最新报告，全球医药运输服务市场规模预计到2030年将达到1,248.1亿美元，2025年至2030年的复合年增长率为7.71%。

该市场的成长主要归因于对温度敏感药物的需求不断增加、医药供应链的扩大以及严格指导方针的实施。

生技药品、疫苗以及细胞和基因疗法的日益普及，正在对医药运输服务市场产生正面影响。与传统的小分子药物不同，生技药品对温度变化和物理处理高度敏感，需要严格的低温运输物流来维持产品完整性。这种需求推动了专用冷藏车、冷藏仓库和包装解决方案的普及，以确保在整个运输过程中不间断地控制温度。包括新冠疫苗分发在内的大规模疫苗接种计划的开展，证明了温控运输的重要性，并加速了对低温运输基础设施的投资。

此外，製药公司越来越多地将生产和分销业务外包给合约开发与受託製造厂商(CDMO) 和物流合作伙伴，进一步扩展了全球供应链。这些复杂的网路跨越多个地区，需要可靠、安全、及时且符合国际和当地监管标准的运输服务。一种药品的组件可能在一个国家生产，在另一个国家组装，并分销到多个市场，因此需要同步的物流规划。随着生产日益分散，对精通清关、文件处理和多式联运的第三方物流供应商 (3PL) 的依赖性也日益增强。此外，亚太、拉丁美洲和东欧等新兴市场已成为重要的生产和消费枢纽，增加了国际药品运输的频率和数量。

此外，包括 DHL、UPS Healthcare、FedEx Express 和 Kuehne+Nagel 在内的几家主要竞争对手正在积极透过策略性投资、合作伙伴关係和技术采用来扩展其能力，以扩大其市场占有率。为了应对日益增长的低温运输物流需求，这些公司正在努力增强其基础设施和服务产品。例如，2025 年 4 月，DHL 向健康物流投资 22.7 亿美元，以根据其 2030 策略加强其生命科学和医疗物流。一半的投资针对美国，其余投资则分配给亚太地区和欧洲、中东和非洲地区，以扩展其全球基础设施。此举加强了 DHL 作为提供以患者为中心的综合医药运输解决方案的主要竞争对手的地位。

医药运输服务市场报告重点

  • 根据类型，生物製药领域在 2024 年占据了市场主导地位。该领域的成长主要归因于对能够处理生技药品、基因治疗药物和个人化药物的高效、安全、合规的运输解决方案的需求不断增长。
  • 按服务划分，航空货运领域在 2024 年占据了市场主导地位。该领域的成长主要归因于对高价值、时间敏感和温控药品快速交付的需求不断增长。
  • 按供应链划分，非低温运输物流领域在 2024 年占据了市场主导地位。该领域的成长受到医疗设备、非处方药 (OTC) 和仿製药分销需求不断增长的推动。

目录

第一章调查方法与范围

第二章执行摘要

第三章医药运输服务市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/辅助市场展望。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 技术格局
  • 定价模式分析
  • 产业市场分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章：医药运输服务市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球医药运输服务市场趋势分析（按类型）
  • 全球医药运输服务市场规模及趋势分析（按类型，2018-2030）
  • 生物製药
    • 疫苗
    • 生物相似药
    • 血浆衍生产品
    • 其他的
  • 製药

第五章：医药运输服务市场：依服务估算与趋势分析

  • 细分仪表板
  • 全球医药运输服务市场服务变化分析
  • 全球医药运输服务市场规模及趋势分析（依服务，2018-2030）
  • 空运
  • 海运
  • 陆上

第六章医药运输服务市场：供应链的估计与趋势分析

  • 细分仪表板
  • 全球医药运输服务市场供应链波动分析
  • 全球医药运输服务市场规模及趋势分析（依供应链，2018-2030）
  • 低温运输物流
  • 非低温运输物流

第七章医药运输服务市场：区域估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 竞争性分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • CEVA Logistics
    • Cencora Corporation（ICS）
    • DB SCHENKER
    • Kuehne+Nagel
    • Kerry Logistics Network Limited
    • Cardinal Health
    • FedEx
    • McKesson Corporation
    • DHL
    • EVERSANA
    • Thermo Fisher Scientific
    • Knipper Health
Product Code: GVR-4-68040-581-6

Pharmaceutical Transportation Services Market Growth & Trends:

The global pharmaceutical transportation services market size is expected to reach USD 124.81 billion by 2030, registering a CAGR of 7.71% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is mainly due to increasing demand for temperature sensitive drugs, expansion of pharmaceutical supply chain, and implementation of stringent guideline.

The growing use of biologics, vaccines, and cell and gene therapies has positively impacted the pharmaceutical transportation services market. Unlike conventional small-molecule drugs, biologics are highly sensitive to temperature variations and physical handling, requiring strict cold chain logistics to maintain product integrity. This demand has led to the proliferation of specialized refrigerated vehicles, cold storage warehouses, and packaging solutions that ensure uninterrupted temperature control throughout the shipping process. The rollout of large-scale vaccination programs, including COVID-19 vaccine distribution, demonstrated the critical importance of temperature-controlled transport and accelerated investment in cold chain infrastructure.

Furthermore, the pharmaceutical companies are increasingly outsourcing manufacturing and distribution activities to contract development and manufacturing organizations (CDMOs) and contract logistics partners, further expanding global supply chains. These complex networks span across regions, creating a need for reliable, secure, and timely transportation services that meet both international and local regulatory standards. Drug components may be produced in one country, assembled in another, and distributed across multiple markets, necessitating synchronized logistics planning. As production decentralizes, the reliance on third-party logistics providers (3PLs) with expertise in navigating customs, documentation, and multi-modal transport has increased. Furthermore, emerging markets in Asia-Pacific, Latin America, and Eastern Europe have become important hubs for both manufacturing and consumption, increasing the frequency and volume of international pharmaceutical shipments.

Furthermore, several key competitors in the market, such as DHL, UPS Healthcare, FedEx Express, and Kuehne+Nagel, are actively expanding capabilities through strategic investments, partnerships, and technology adoption to gain market share. The rising demand for cold chain logistics has led these players to enhance their infrastructure and service offerings. For instance, in April 2025, DHL invested USD 2.27 billion in health logistics to strengthen its life sciences and healthcare logistics, aligning with its "Strategy 2030." Half of the investment targets the U.S., with the rest split between Asia Pacific and EMEA, expanding global infrastructure. This move reinforces DHL's role as a key competitor in providing integrated, patient-focused pharmaceutical transportation solutions.

Pharmaceutical Transportation Services Market Report Highlights:

  • Based on type, the biopharmaceuticals segment dominated the market in 2024. The growth of this segment is largely attributed to the rising demand for efficient, secure, and compliant transportation solutions capable of handling biologics, gene therapies, and personalized medications.
  • Based on the services, the air freight segment dominated the market in 2024. The growth of this segment is largely attributed to the increasing demand for rapid delivery of high-value, time-sensitive, and temperature-controlled pharmaceutical products.
  • Based on the supply chain, the non-cold chain logistics segment dominated the market in 2024. The segment's growth is due to the rising demand for medical devices, over the counter (OTC) drugs, and general pharmaceutical distribution.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Purchased Database
    • 1.3.3. GVR's Internal Database
    • 1.3.4. Secondary Sources
    • 1.3.5. Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Information Analysis
    • 1.4.2. Market Formulation & Data Visualization
    • 1.4.3. Data Validation & Publishing
  • 1.5. Model Details
    • 1.5.1. Commodity Flow Analysis (Model 1)
    • 1.5.2. Top Down Market Estimation (Model 2)
    • 1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
    • 1.5.4. Multivariate Analysis (Model 4)
  • 1.6. List of Secondary Sources
  • 1.7. List of Abbreviations
  • 1.8. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Pharmaceutical Transportation Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising Demand for Biopharmaceuticals and Specialty Drugs
      • 3.2.1.2. Expansion of Global Pharmaceutical Supply Chain
      • 3.2.1.3. Stringent Regulatory Requirements and Quality Assurance Standards
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost of Cold Chain Infrastructure and Maintenance
      • 3.2.2.2. Complex Regulatory and Customs Compliance Across Regions
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Industry Market Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Transportation Services Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Pharmaceutical Transportation Services Market Type Movement Analysis
  • 4.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Biopharmaceuticals
    • 4.4.1. Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Vaccines
      • 4.4.2.1. Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Biosimilars
      • 4.4.3.1. Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Plasma Derived Products
      • 4.4.4.1. Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pharmaceuticals
    • 4.5.1. Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Transportation Services Market: Services Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Pharmaceutical Transportation Services Market Services Movement Analysis
  • 5.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Services, 2018 to 2030 (USD Million)
  • 5.4. Air Freight
    • 5.4.1. Air Freight market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Sea Freight
    • 5.5.1. Sea Freight market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Overland
    • 5.6.1. Overland market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Transportation Services Market: Supply Chain Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Pharmaceutical Transportation Services Market Supply Chain Movement Analysis
  • 6.3. Global Pharmaceutical Transportation Services Market Size & Trend Analysis, by Supply Chain, 2018 to 2030 (USD Million)
  • 6.4. Cold Chain Logistics
    • 6.4.1. Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5. Non-cold Chain Logistics
    • 6.5.1. Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Transportation Services Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size & Forecasts Trend Analysis, 2018 to 2030 (USD Million)
  • 7.4. North America
    • 7.4.1. North America Market Estimates and Forecasts 2018 to 2030, (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory scenario
      • 7.4.2.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory scenario
      • 7.4.3.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory scenario
      • 7.4.4.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory scenario
      • 7.5.2.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory scenario
      • 7.5.3.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory scenario
      • 7.5.4.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory scenario
      • 7.5.5.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory scenario
      • 7.5.6.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory scenario
      • 7.5.7.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory scenario
      • 7.5.8.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.5.9. Sweden
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory scenario
      • 7.5.9.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory scenario
      • 7.6.2.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory scenario
      • 7.6.3.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory scenario
      • 7.6.4.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory scenario
      • 7.6.5.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory scenario
      • 7.6.6.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory scenario
      • 7.6.7.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory scenario
      • 7.7.2.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory scenario
      • 7.7.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory scenario
      • 7.8.2.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory scenario
      • 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory scenario
      • 7.8.4.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory scenario
      • 7.8.5.4. Israel market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Competition Categorization
  • 8.2. Company Market Share/Assessment Analysis, 2024
  • 8.3. Company Profiles
    • 8.3.1. CEVA Logistics
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Service benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Cencora Corporation (ICS)
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Service benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. DB SCHENKER
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Service benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Kuehne+Nagel
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Service benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Kerry Logistics Network Limited
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Service benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Cardinal Health
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Service benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. FedEx
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Service benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. McKesson Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Service benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. DHL
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Service benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. EVERSANA
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Service benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Thermo Fisher Scientific
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Service benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Knipper Health
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Service benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 5 Global pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 6 Global pharmaceutical transportation services Market, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 9 North America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 10 U.S. pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 12 U.S. pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 13 Canada pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 15 Canada pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 16 Mexico pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 18 Mexico pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 19 Europe pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Europe pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 22 Europe pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 23 Germany pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 25 Germany pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 26 UK pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 27 UK pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 28 UK pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 29 France pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 30 France pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 31 France pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 32 Italy pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Italy pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 34 Italy pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 35 Spain pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Spain pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 37 Spain pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 38 Denmark pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 40 Denmark pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 41 Norway pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Norway pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 43 Norway pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 44 Sweden pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 45 Sweden pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 46 Sweden pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 51 China pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 52 China pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 53 China pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 54 Japan pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Japan pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 56 Japan pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 57 India pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 58 India pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 59 India pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 60 South Korea pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 62 South Korea pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 63 Australia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Australia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 65 Australia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 66 Thailand pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 68 Thailand pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 69 Latin America pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 72 Latin America pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 73 Brazil pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 75 Brazil pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 76 Argentina pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 77 Argentina pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 78 Argentina pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa pharmaceutical transportation services Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 83 South Africa pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 85 South Africa pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 89 UAE pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 90 UAE pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 91 UAE pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)
  • Table 92 Kuwait pharmaceutical transportation services Market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pharmaceutical transportation services Market, by Services, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pharmaceutical transportation services Market, by Supply Chain, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Pharmaceutical Transportation Services Market Segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot 1
  • Fig. 14 Segment snapshot 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL by SWOT analysis
  • Fig. 19 Pharmaceutical transportation services market: Type outlook key takeaways
  • Fig. 20 Pharmaceutical transportation services market: Type movement analysis
  • Fig. 21 Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Biosimilars market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Plasma Derived Products market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Pharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Pharmaceutical Transportation Services Market: Services outlook key takeaways
  • Fig. 28 Pharmaceutical Transportation Services Market: Services movement analysis
  • Fig. 29 Cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Non-cold Chain Logistics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 32 Regional marketplace: Key takeaways
  • Fig. 33 North America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 U.S. pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Canada pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Mexico pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Europe pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 UK regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 France pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 Italy pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Spain pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Denmark pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Norway pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Japan pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 China pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 India pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Australia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Thailand pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 MEA pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 South Africa pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Saudi Arabia pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 UAE pharmaceutical transportation services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Kuwait regulatory affairs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Market participant categorization
  • Fig. 87 Precision medicine market share/assessment analysis, 2024
  • Fig. 88 Strategic framework